Thus, in the current study, we evaluated the impact of sex on the efficacy of first‐line PD‐1 blockade in combination with chemotherapy or chemotherapy alone in patients with advanced or metastatic NSCLC. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.